Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for high-purity quinazolinone derivatives, offering significant supply chain advantages.
Patent CN112480015B discloses a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, scalable process for API intermediates.
Novel FeCl3-catalyzed route offers high yields and scalability for drug intermediates, reducing costs in API manufacturing significantly.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for pharmaceutical intermediates.
Patent CN113045503A details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate production.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate manufacturing solutions.
Novel Pd-catalyzed carbonylation method offers high yields and substrate tolerance for scalable drug molecule production.
Novel FeCl3-catalyzed route offers high yields and scalability for quinazolinone derivatives, reducing costs in API manufacturing.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API intermediates.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates using cheap nitro compounds.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high efficiency and substrate compatibility for pharmaceutical intermediates.
Patent CN112125856A details a safe Pd-catalyzed carbonylation using solid CO surrogates, offering reliable pharmaceutical intermediate supply chains.
Patent CN111675662B reveals FeCl3-catalyzed route offering high yields and cost-effective manufacturing for complex heterocyclic scaffolds.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and scalable production.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API intermediates.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for quinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN111675662A reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.